Proteomics studies can be applied to advance early- to mid-stage drug discovery and development efforts. From total proteome, to post-translational modification analysis, to signaling pathway elucidation, proteomics studies can increase effectiveness and decrease timelines for target/biomarker identification and understanding of mechanism of action and off-target effects.
Presenter: Matthew P. Stokes, PhD, Associate Director, Proteomics and Services, Cell Signaling Technology.
Your work in the discovery pipeline:
Challenges you may be facing: